Comunicati Stampa
Salute e Benessere

Nevisense (EIS) included in updated German (S1) imaging guidelines

"The guidelines have a primary focus on imaging technologies, so it is very positive that they include Nevisense and state that it is a valuable technology in detecting skin cancer. The guideline includes the potential future of new applications within AD. This is another step forward in the adoption of our technology in Germany", said Pia Renaudin, CEO of SciBase. "The guidelines have a primary focus on imaging technologies, so it is very positive that they include Nevisense and state that it...
STOCKHOLM, Sweden, (informazione.news - comunicati stampa - salute e benessere)

"The guidelines have a primary focus on imaging technologies, so it is very positive that they include Nevisense and state that it is a valuable technology in detecting skin cancer. The guideline includes the potential future of new applications within AD. This is another step forward in the adoption of our technology in Germany ", said Pia Renaudin , CEO of SciBase.

The guidelines (in German) can be found here: https://derma.de/fileadmin/derma/1_derma.de_WebRoot/Leitlinien/013-076l_S1_Bildgebende-Diagnostik-von-Hauterkrankungen_2024-11-komprimiert.pdf


Pia Renaudin , CEO, tel. +46732069802, e-mail: pia.renaudin@scibase.com

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se


 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/nevisense--eis--included-in-updated-german--s1--imaging-guidelines-,c4095345

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/nevisense-eis-included-in-updated-german-s1-imaging-guidelines-302358874.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili